← SynDRA
Lopac-R-5523
SynDRA canonical compound SYN0103272 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ALOX5 |
|---|
| Mechanism of action | Leukotriene receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Lipoxygenase inhibitor
- Leukotriene receptor antagonist
- ALOX5 INHIBITOR
Drug classes
- Anti-Inflammatory Agents, Non-Steroidal
- Antioxidants
- Lipoxygenase Inhibitors
- Platelet Aggregation Inhibitors
Cross-references
Synonyms
- NCGC00015895-01
- CHEMBL8747
- 1-(3-(quinolin-2-ylmethoxy)phenyl)hexan-1-ol
- KBio3_000484
- MLS000069771
- NCGC00015895-04
- KBioSS_000242
- NCGC00015895-02
- 1-[3-(2-quinolinylmethoxy)phenyl]-1-hexanol
- AKOS000278774
- UNII-WNW5RYD8MG
- PF-5901
- CBiol_001910
- Bio1_000685
- HMS2232F10
- NCGC00094327-02
- HMS3649O15
- Bio1_000196
- .ALPHA.-PENTYL-3-(2-QUINOLINYLMETHOXY)BENZENEMETHANOL
- 1-[3-(Quinolin-2-ylmethoxy)-phenyl]-hexan-1-ol(Rev-5901)
- Opera_ID_512
- WNW5RYD8MG
- ACMC-20d0wb
- RG 5901
- alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol
- HMS3402M04
- Lopac0_001042
- SR-01000076105-7
- R 5523
- SR-01000076105
- REV-901
- NCGC00094327-04
- Benzenemethanol, alpha-pentyl-3-(2-quinolinylmethoxy)-
- NCGC00015895-05
- Rev 5901
- [3-(1-hydroxyhexyl)phenoxymethyl]quinoline
- EU-0101042
- BSPBio_001522
- NCGC00094327-03
Look up Lopac-R-5523 in the interactive SynDRA portal →